Pliant Therapeutics, Inc (PLRX) insider trading
Every open-market stock purchase and sale by Pliant Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $164K over the last 12 months (4 sales). No open-market buys.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $164K (4 sales). Last close $1.12 on Jul 15, 2026.
Recent PLRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 9, 2026 | Flavia Borellini (Director) | Bought (not open market) | — |
| Jul 9, 2026 | Robert Iannone (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Hoyoung Huh (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Steve E. Krognes (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Gayle A Crowell (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Darren S Cline (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Thomas A MCCOURT (Director) | Bought (not open market) | — |
| Jun 11, 2026 | John T Curnutte (Director) | Bought (not open market) | — |
| Apr 17, 2026 | Bernard Coulie (CEO) | Bought (not open market) | — |
| Apr 17, 2026 | Keith Lamont Cummings (CFO) | Sold (not open market) | — |
| Apr 17, 2026 | Keith Lamont Cummings (CFO) | Bought (not open market) | — |
| Apr 17, 2026 | Keith Lamont Cummings (CFO) | Sold (not open market) | — |
| Apr 17, 2026 | Keith Lamont Cummings (CFO) | Bought (not open market) | — |
| Apr 17, 2026 | Bernard Coulie (CEO) | Sold (not open market) | — |
| Apr 17, 2026 | Keith Lamont Cummings (CFO) | Sold (not open market) | — |
| Apr 17, 2026 | Keith Lamont Cummings (CFO) | Bought (not open market) | — |
| Apr 17, 2026 | Bernard Coulie (CEO) | Bought (not open market) | — |
| Apr 17, 2026 | Minnie Kuo (COO) | Sold (not open market) | — |
| Apr 17, 2026 | Lily Cheung (Officer) | Bought (not open market) | — |
| Apr 17, 2026 | Bernard Coulie (CEO) | Bought (not open market) | — |
| Apr 17, 2026 | Bernard Coulie (CEO) | Sold (not open market) | — |
| Apr 17, 2026 | Bernard Coulie (CEO) | Sold (not open market) | — |
| Apr 17, 2026 | Bernard Coulie (CEO) | Sold (not open market) | — |
| Apr 17, 2026 | Bernard Coulie (CEO) | Bought (not open market) | — |
| Apr 17, 2026 | Keith Lamont Cummings (CFO) | Sold (not open market) | — |
Who's trading PLRX
- Flavia Borellini, Director: other filings, last Jul 9, 2026
- Robert Iannone, Director: other filings, last Jul 9, 2026
- Darren S Cline, Director: other filings, last Jun 11, 2026
- Thomas A MCCOURT, Director: other filings, last Jun 11, 2026
- Gayle A Crowell, Director: other filings, last Jun 11, 2026
- John T Curnutte, Director: other filings, last Jun 11, 2026
- Hoyoung Huh, Director: other filings, last Jun 11, 2026
- Steve E. Krognes, Director: other filings, last Jun 11, 2026
- Bernard Coulie, CEO: sold $114K (1 sale), last Apr 17, 2026
- Keith Lamont Cummings, CFO: sold $30.7K (1 sale), last Apr 17, 2026
- Lily Cheung, Officer: sold $9.6K (1 sale), last Apr 17, 2026
- Minnie Kuo, COO: sold $8.9K (1 sale), last Apr 17, 2026
Get free alerts when an insider at Pliant Therapeutics, Inc files a new trade →